How long can meds be stored in Rx Crush pouches - BUD question

There is no single universal expiration date for all crushed medications. Because crushing alters the physical properties of a drug, the Beyond-Use Date (BUD) is determined by standard compounding guidelines, specific stability data for the individual drug, and your hospital’s internal policies.

If a hospital pharmacy is pre-crushing tablets and repackaging them into unit-dose pouches for nursing staff, here is the documentation and regulatory framework you need to follow:

1. The Governing Standard: USP <795>

Under the United States Pharmacopeia (USP) Chapter <795> for Nonsterile Compounding, crushing a manufactured solid tablet and repackaging it as a powder alters its dosage form and is considered compounding.

  • The Maximum Allowance: According to USP <795>, the maximum BUD for a solid, non-aqueous preparation (like powder in a moisture-resistant pouch) is 180 days (6 months) or the remaining expiration date of the original manufactured product, whichever is shorter.  

  • The Stability Caveat: This 180-day rule only applies if the chemical stability of the drug is maintained. Crushing a tablet destroys its protective outer coating and drastically increases the surface area exposed to oxygen, ambient moisture, and light, which rapidly accelerates degradation for many molecules.

2. Standard Hospital Pharmacy Practice

Because exact stability data for the powdered form of most medications does not exist, assigning a 180-day BUD is risky. Most hospital pharmacies adopt one of the following approaches:

  • Immediate Administration (Standard Protocol): Nursing guidelines (like those from the Institute for Safe Medication Practices) strongly recommend that non-hazardous medications be crushed by the nurse at the bedside immediately prior to administration to prevent drug loss and degradation.

  • Conservative Pharmacy BUDs: When the pharmacy must pre-crush a medication—usually for hazardous drugs governed by USP <800> that must be crushed under a bio-safety hood to protect nursing staff—they typically assign a highly conservative BUD of 24 to 72 hours unless specific peer-reviewed stability data supports a longer duration.

3. Where to Find Specific Documentation

To establish a pharmacy's policy, you should consult the following resources:

  • Manufacturer Package Inserts: Check the "Dosage and Administration" or "Stability" sections. If a manufacturer has tested their drug in a crushed state, they will explicitly state how long it remains stable (e.g., some specify the powder is stable for 2 hours, others for 24 hours).  

  • Trissel’s Stability of Compounded Formulations: This is the gold-standard pharmacy reference text for finding peer-reviewed stability data on specific crushed or compounded drugs.
  • Your Hospital's Policies & Procedures (P&P): Your facility's Pharmacy and Therapeutics (P&T) committee should have an established policy for unit-dose repackaging and nonsterile compounding BUDs.

Important Note: Before establishing a pre-crushing workflow, verify that the medication is safe to crush. Enteric-coated (EC), sustained-release (SR), extended-release (XR/ER), and sublingual medications must never be crushed, as doing so leads to "dose dumping" and potential toxicity.  

 

If you are setting up this workflow, It's recommended pulling the top 10-15 medications your pharmacy routinely crushes (such as hazardous oral solids) and checking a compounding database like Lexicomp or Trissel's to create a specific BUD chart for those specific drugs.

  • Immediate Administration (Standard Protocol): Nursing guidelines (like those from the Institute for Safe Medication Practices) strongly recommend that non-hazardous medications be crushed by the nurse at the bedside immediately prior to administration to prevent drug loss and degradation.

  • Conservative Pharmacy BUDs: When the pharmacy must pre-crush a medication—usually for hazardous drugs governed by USP <800> that must be crushed under a bio-safety hood to protect nursing staff—they typically assign a highly conservative BUD of 24 to 72 hours unless specific peer-reviewed stability data supports a longer duration.

Trissel’s Stability of Compounded Formulations: This is the gold-standard pharmacy reference text for finding peer-reviewed stability data on specific crushed or compounded drugs.

The Governing Standard: USP <795>   Under the United States Pharmacopeia (USP) Chapter <795> for Nonsterile Compounding, crushing a manufactured solid tablet and repackaging it as a powder alters its dosage form and is considered compounding USP<795> Compounding Standards and Beyond-Use Dates (BUDs)

Important Note: Before establishing a pre-crushing workflow, verify that the medication is safe to crush. Enteric-coated (EC), sustained-release (SR), extended-release (XR/ER), and sublingual medications must never be crushed, as doing so leads to "dose dumping" and potential toxicity.

If you are setting up this workflow, It's recommended to sample the top 10-15 medications your pharmacy routinely crushes (such as hazardous oral solids) and checking a compounding database like Lexicomp or Trissel's to create a specific BUD chart for those specific drugs.

Conflicting views: The FDA and USP have different opinions about how long medications can be kept after compounding. Also there is a question about how far a medication can be transported out of the pharmacy for safety. Premier Inc has issued an opinion letter to the FDA encouraging the FDA and USP to align their guidance. The letter is accessible through Premier Inc's web site. https://www.premierinc.com/newsroom/policy/premier-recommends-compounding-reforms-to-prevent-drug-shortages

Back to blog